Bank of Montreal Can Has $261.31 Million Position in Intuitive Surgical, Inc. $ISRG

Bank of Montreal Can lowered its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 8.2% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 480,878 shares of the medical equipment provider’s stock after selling 43,188 shares during the quarter. Bank of Montreal Can owned about 0.13% of Intuitive Surgical worth $261,314,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Vanguard Group Inc. boosted its holdings in shares of Intuitive Surgical by 1.4% during the 1st quarter. Vanguard Group Inc. now owns 32,665,531 shares of the medical equipment provider’s stock worth $16,178,258,000 after buying an additional 453,335 shares during the period. Invesco Ltd. raised its holdings in Intuitive Surgical by 1.7% in the 1st quarter. Invesco Ltd. now owns 4,219,974 shares of the medical equipment provider’s stock worth $2,090,027,000 after acquiring an additional 71,794 shares during the period. Northern Trust Corp raised its holdings in Intuitive Surgical by 0.3% in the 1st quarter. Northern Trust Corp now owns 3,631,281 shares of the medical equipment provider’s stock worth $1,798,465,000 after acquiring an additional 11,988 shares during the period. Wellington Management Group LLP lifted its position in Intuitive Surgical by 15.0% during the 1st quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider’s stock worth $1,732,975,000 after acquiring an additional 457,080 shares during the last quarter. Finally, Nuveen LLC bought a new stake in Intuitive Surgical during the first quarter valued at about $1,715,899,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Wall Street Analyst Weigh In

ISRG has been the topic of several research analyst reports. Jefferies Financial Group raised their price target on Intuitive Surgical from $550.00 to $560.00 and gave the company a “hold” rating in a research report on Wednesday, October 22nd. Truist Financial set a $620.00 target price on Intuitive Surgical and gave the company a “buy” rating in a research note on Wednesday, October 22nd. Rothschild & Co Redburn lifted their price target on Intuitive Surgical from $610.00 to $615.00 and gave the stock a “buy” rating in a research report on Thursday, October 23rd. Evercore ISI upped their price target on Intuitive Surgical from $450.00 to $540.00 in a report on Wednesday, October 22nd. Finally, Erste Group Bank reissued a “hold” rating on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Two research analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus price target of $608.92.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, Director Amy L. Ladd sold 336 shares of Intuitive Surgical stock in a transaction on Wednesday, September 3rd. The shares were sold at an average price of $470.11, for a total transaction of $157,956.96. Following the sale, the director owned 1,074 shares in the company, valued at $504,898.14. The trade was a 23.83% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Gary S. Guthart sold 29,360 shares of the business’s stock in a transaction on Friday, August 29th. The shares were sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the completion of the sale, the insider directly owned 19,827 shares in the company, valued at $9,368,059.23. This trade represents a 59.69% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 96,011 shares of company stock valued at $50,309,042 over the last 90 days. Corporate insiders own 0.70% of the company’s stock.

Intuitive Surgical Stock Up 0.8%

Shares of ISRG opened at $534.28 on Monday. The stock’s 50-day moving average price is $464.32 and its 200 day moving average price is $498.73. The firm has a market capitalization of $191.53 billion, a price-to-earnings ratio of 70.67, a P/E/G ratio of 4.94 and a beta of 1.61. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, topping analysts’ consensus estimates of $1.99 by $0.41. The company had revenue of $2.51 billion during the quarter, compared to the consensus estimate of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The company’s quarterly revenue was up 22.9% on a year-over-year basis. During the same quarter last year, the company earned $1.84 EPS. Equities research analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.